Business

AYURCANN HOLDINGS CORP. Announced a repurchase of common stock based on the Canadian Business Journal’s regular course issuer bid.

Toronto, Ontario, March 1, 2022 (GLOBE NEWSWIRE) — Ayurkan Holdings Co., Ltd. ((((CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurkan” or “Ltd”), A leading Canadian cannabis extractor specializing in the processing and co-manufacturing of pharmaceutical grade cannabis and hemp for the production of various derivative cannabis 2.0 and 3.0 products in the pharmaceutical and entertainment markets, has begun its regular course. Announced the intention to do so. Issuer bid (“NCIB“) Through the facilities of the Canadian Stock Exchange (“CSE”) Or alternative trading system

Under NCIB, Kosha will acquire up to 6,085,890 shares of common stock in Kosha’s capital (“General stock”), Equivalent to about 5% of issued common stock. As of February 28, 2022, the number of issued common shares was 121,717,818. One day, during the NCIB period, Kommuninvest can only buy up to 15,000 shares of common stock. This represents 25% of the average daily trading volume of 60,000 calculated based on the CSE trading volume over the last 12 months. In block trading, you buy more common stock once a calendar week.

Purchases under the NCIB will begin on March 1, 2022 and will end on the earlier of the following: (I) February 28, 2023. Or (ii) the date on which we purchased the maximum number of common shares to be acquired under NCIB. Kosha may terminate NCIB early if it deems it appropriate.

Kosha is a Canaccord Genuity Corp to implement NCIB. Has been appointed. Purchases and payments of common stock are made in accordance with CSE requirements and applicable securities laws. The number of common shares actually purchased, the timing of purchase, and the stock price will vary depending on the market conditions at that time and the requirements of the securities law. All acquired common stock will be returned to the Ministry of Finance and canceled.

Our Board of Directors believes that the market price of common stock may not reflect our underlying value, especially its growth opportunities, and that the proposed purchase of common stock is in our best interests. .. And it represents the proper use of corporate funds. Kosha purchases are also expected to increase shareholder value and liquidity.

About Ayurkan

Ayurcann is a leading post-harvest solution provider focused on delivering and creating custom processes and pharmaceutical grade products for the Canadian adult and medical cannabis industry. Ayurcann strives to be the leader in Canadian and international cannabis brands by offering best-in-class, unique services such as extraction, formulation, product development and custom manufacturing.

For more information, please contact:

Ayurkan Holdings Co., Ltd.
Igal Sudman, CEO
905-492-3322
info@ayurcann.com

Investor Public Relations:

Email: ir@ayurcann.com

Neither the Canadian Stock Exchange nor its regulatory service provider reviews or is responsible for the validity or accuracy of this release.

Description of future prospects

This news release contains “forward-looking statements” in the sense of applicable securities law. All statements contained in this document that are not clearly historical in nature may constitute forward-looking statements. In general, such forward-looking information or forward-looking statements such as “plan”, “expect” or “not expect”, “expected”, “budget”, “planned”, etc. Can be identified using terms related to. , “Estimate”, “Prediction”, “Intention”, “Prediction”, “Unexpected”, “Believe”, or a variation of such a word or phrase, or a particular action, event, or result is “possible” The statement “is” may be included, “done”, “would”, “may” or “taken”, “continue”, “occur” or “achieved”. The forward-looking information and forward-looking statements contained in this document include, but are not limited to, the following: tThe corporation launched NCIB and purchased common stock to cancel under it.; Ability of companies to be selected as partners of Canada’s leading cannabis brands.

Information about the future outlook for this news release is based on certain assumptions and expected future events. Ability of a company to survive as a going concern. Continued approval of Kosha’s activities by relevant governments and / or regulatory agencies. Kosha’s continuous growth. Of a corporation Successful implementation Strategies to increase market share of extracts and extract derivatives While providing excellent products to consumers; Kosha’s ongoing ability to meet the requirements needed to stay listed About CSE and alternative replacement; Repurchase of common stock under NCIB Ability of companies to be selected as partners of Canada’s leading cannabis brands.

These statements include known and unknown risks, uncertainties, and other factors, and actual results, performance, or outcomes may differ materially from those expressed or implied by these statements. There is sex. This includes, but is not limited to: Capacity; A company that may not be able to continue as a going concern. Risks associated with the cannabis industry in general. Intensifying competition in the cannabis extraction market.Potential future infeasibility of the cannabis market; risks associated with potential government and / or regulatory measures for the cannabis industry; The inability to acquire a corporation continues Regulation Approvals; We are unable to successfully implement strategies to increase market share of extracts and extract derivatives in the meantime Providing superior products to consumers; Companies that cannot meet the required requirements to remain listed in Alternative exchange with CSE; Kosha does not buy back common stock under NCIB; And that Corporation cannot be selected as a partner for Canada’s major cannabis brands.

Readers should note that the above list is not exhaustive. Readers should also be careful not to place undue reliance on forward-looking statements. There is no guarantee that any plans, intentions, or expectations will arise in which they will be placed. Such information is Preparation management can prove inaccurate and actual results can vary significantly from expectations.

The forward-looking statements contained in this news release are expressly modified by this notice and reflect our expectations as of today and are subject to change. Whether we explain significant differences between new information, quotes or opinions, future events or consequences, or subsequent actual events and information about such future prospects, in the future. We undertake no obligation to update or revise any statement regarding our outlook. Except as required by applicable law.

This press release does not constitute an offer to sell or solicit a purchase, and there is no sale of securities in any state where such offer, solicitation or sale is illegal. The securities offered are not registered under the Securities Act of 1933 (Amendment) and are not registered. It may not be offered or sold in the United States without the applicable exemption from registration or registration requirements in the United States. The revised Securities Act of 1933 and the applicable State Securities Act.


CBJ News Maker

AYURCANN HOLDINGS CORP. Announced a repurchase of common stock based on the Canadian Business Journal’s regular course issuer bid.

Source link AYURCANN HOLDINGS CORP. Announced a repurchase of common stock based on the Canadian Business Journal’s regular course issuer bid.

Related Articles

Back to top button